Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma, Myxoid × Pioglitazone × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Liposarcoma, Myxoid 1 Liposarcoma 1

Interventions

Cyclophosphamide 13 fludarabine 7 Trabectedin 4 Radiation Dose Hypofractionation 3 seclidemstat 2 pembrolizumab 2 Topotecan 2 Interferon-gamma 2 selinexor 1 pazopanib 1 palbociclib 1 mirdametinib 1 itacitinib 1 interferon gamma-1b 1 fludarabine phosphate 1 brostallicin 1 baricitinib 1 atezolizumab 1 aldesleukin 1 X-Rays 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Pioglitazone 1 Phantoms, Imaging 1 Magnetic Resonance Spectroscopy 1 Leukapheresis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡